You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 286 No. 13, October 3, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Pediatrics
 •Neonatology and Infant Care
 •Women's Health
 •Pregnancy and Breast Feeding
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antenatal Corticosteroids—Too Much of a Good Thing?

Edward E. Lawson, MD

JAMA. 2001;286:1628-1630.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Changes in management regarding care of neonates resemble the swings of a pendulum. As the force of gravity keeps a pendulum from swinging too far, continuing medical research keeps management from becoming too extreme. Research permits evaluation of the risks and benefits of a particular treatment, advancing knowledge to refine the risk-benefit ratio and alter clinical care. Unfortunately, despite apparently proper research protocols, physicians do not always correctly understand risks and benefits regarding any specific issue. Therefore, occasionally the recommended management may become transiently out of phase with the ultimate "best practice."

For years, physicians have known that antenatal betamethasone or dexamethasone, when administered at least 24 hours before delivery, reduces the incidence of respiratory distress syndrome (RDS) in neonates between 24 and 32 weeks' gestation. Consensus on this point swung through phases as early studies supported the use of antenatal corticosteroids,1-3 then a major National . . . [Full Text of this Article]

Author Affiliation: Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Single vs Weekly Courses of Antenatal Corticosteroids for Women at Risk of Preterm Delivery: A Randomized Controlled Trial
, , , , , , , , , , , , and
JAMA. ;286():1581-1587.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Giving steroids before elective caesarean section
Steer
BMJ 2005;331:645-646.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.